Manulife (Manufacturers Life Insurance)
AVIR icon

Manulife (Manufacturers Life Insurance)’s Atea Pharmaceuticals AVIR Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$82.3K Sell
17,698
-2,474
-12% -$12.3K ﹤0.01% 2780
2026
Q1 		$109K Sell
20,172
-3,795
-16% -$17.4K ﹤0.01% 2605
2025
Q4 		$85.6K Sell
23,967
-6,136
-20% -$19.5K ﹤0.01% 2739
2025
Q3 		$87.3K Sell
30,103
-2,638
-8% -$9.01K ﹤0.01% 2802
2025
Q2 		$118K Buy
32,741
+2,172
+7% +$6.48K ﹤0.01% 2728
2025
Q1 		$91.4K Sell
30,569
-1,772
-5% -$5.53K ﹤0.01% 2714
2024
Q4 		$108K Sell
32,341
-1,213
-4% -$4.03K ﹤0.01% 2802
2024
Q3 		$112K Sell
33,554
-1,332
-4% -$4.83K ﹤0.01% 2836
2024
Q2 		$115K Buy
34,886
+4,339
+14% +$16.2K ﹤0.01% 2788
2024
Q1 		$123K Sell
30,547
-2,438
-7% -$9.54K ﹤0.01% 2731
2023
Q4 		$101K Hold
32,985
– – ﹤0.01% 2817
2023
Q3 		$99K Buy
32,985
+46
+0.1% +$157 ﹤0.01% 2812
2023
Q2 		$123K Buy
32,939
+2,532
+8% +$9.48K ﹤0.01% 2768
2023
Q1 		$102K Sell
30,407
-189,700
-86% -$770K ﹤0.01% 2740
2022
Q4 		$1.06M Buy
220,107
+310
+0.1% +$1.57K ﹤0.01% 1580
2022
Q3 		$1.25M Sell
219,797
-511
-0.2% -$3.91K ﹤0.01% 1516
2022
Q2 		$1.56M Sell
220,308
-38,347
-15% -$262K ﹤0.01% 1482
2022
Q1 		$1.86M Buy
258,655
+35,000
+16% +$238K ﹤0.01% 1529
2021
Q4 		$2.01M Sell
223,655
-59,768
-21% -$931K ﹤0.01% 1497
2021
Q3 		$9.94M Sell
283,423
-3,417
-1% -$94.8K 0.01% 934
2021
Q2 		$6.16M Buy
286,840
+27,364
+11% +$822K 0.01% 1180
2021
Q1 		$16M Buy
259,476
+1,191
+0.5% +$80.5K 0.01% 750
2020
Q4 		$10.8M Buy
+258,285
New +$8.33M 0.01% 859

Other funds holding AVIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s AVIR Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Atea Pharmaceuticals (AVIR) stake by 12% in Q2 2026, selling an estimated $12.3K and leaving 17,698 shares worth $82.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2780.

Manulife (Manufacturers Life Insurance) first reported a position in AVIR in Q4 2020 and has held it in 23 quarters since. The position peaked at $16M in Q1 2021. 124 funds tracked by Wall St. Rank hold AVIR as of Q2 2026.

  • Manulife (Manufacturers Life Insurance) held 17,698 shares of Atea Pharmaceuticals worth $82.3K as of Q2 2026.
  • Manulife (Manufacturers Life Insurance) sold 2,474 Atea Pharmaceuticals shares in Q2 2026, an estimated $12.3K.
  • Atea Pharmaceuticals made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #2780 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Atea Pharmaceuticals in Q4 2020 and has held it in 23 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Atea Pharmaceuticals position peaked at $16M in Q1 2021.
  • 124 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.